Arteris, Inc. (AIP) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Arteris, Inc. is a provider of semiconductor system IP, specifically Network-on-Chip (NoC) interconnect technology and SoC Integration Automation software. The company operates globally with offices in the U.S., France, Japan, South Korea, China, and is establishing a presence in Poland. As of June 30, 2024, the company had 252 full-time employees.
Key Financial Metrics
| Metric (in thousands) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Total Revenue | $14,575 | $14,734 | $27,522 | $27,888 |
| Gross Profit | $13,117 | $13,509 | $24,596 | $25,539 |
| Gross Margin | 90.0% | 91.7% | 89.4% | 91.6% |
| Net Loss | $(8,344) | $(9,165) | $(17,747) | $(18,175) |
| Diluted EPS | $(0.22) | $(0.26) | $(0.47) | $(0.52) |
| Cash & Equivalents | $22,128 | N/A | N/A | N/A |
| Total Investments | $31,753 | N/A | N/A | N/A |
| Operating Cash Flow (YTD) | $788 | $(9,944) | N/A | N/A |
Note: Total Investments includes short-term ($23.6M) and long-term ($8.1M) investments.
Material Changes vs. Prior Period
- Revenue: Total revenue decreased slightly by 1% in Q2 2024 compared to Q2 2023. Licensing, support, and maintenance revenue increased by 4% ($13.6M vs $13.0M), while variable royalties declined significantly by 43% ($1.0M vs $1.7M) due to the absence of fixed/up-front royalties received in Q2 2023.
- Expenses: Total operating expenses decreased by 7% to $20.6M. Research and Development (R&D) expenses dropped 11% primarily due to lower stock-based compensation and R&D grants received by the French subsidiary. Sales and Marketing expenses fell 10% due to reduced event costs.
- Liquidity: Cash and cash equivalents increased to $22.1M from $13.7M at year-end 2023. The company generated positive operating cash flow of $0.8M for the six months ended June 30, 2024, a significant improvement from the $9.9M outflow in the prior year period.
- Deferred Revenue: Deferred revenue increased to $61.4M (current and non-current combined), indicating a strong backlog of contracted revenue.
Outlook, Risks, and Management Commentary
- Key Performance Indicators: Annual Contract Value (ACV) grew to $56.1M as of June 30, 2024, up from $53.6M in the prior year. The company recorded 21 Confirmed Design Starts in Q2 2024.
- Geopolitical Risks: Approximately 30.1% of YTD 2024 revenue was derived from customers in China. Management highlights risks associated with U.S. export controls and trade restrictions that may limit business with certain Chinese entities, particularly in advanced AI and supercomputer sectors.
- Legal Proceedings: The company is involved in patent litigation with Network System Technologies, LLC (NST). A stay of deadlines was granted in June 2024, with a stipulation of dismissal expected after a discovery motion is resolved. Management states the outcome is unpredictable and could materially impact financial results.
- Profitability: The company continues to incur net losses and has an accumulated deficit of $121.0M. Management expects R&D expenses to increase in absolute terms in the near term but decrease as a percentage of revenue in the medium to long term.
Investor Verification Checklist
- China Exposure: Verify the specific impact of recent U.S. export control regulations on the 30% of revenue derived from China.
- Royalty Volatility: Assess the sustainability of royalty revenue given the 43% drop in Q2 2024 and the company's reliance on customer product volume.
- Legal Contingency: Monitor the resolution of the NST patent litigation and potential financial exposure.
- Cash Burn vs. Runway: Confirm that the current cash position ($45.8M in cash and short-term investments) is sufficient to fund operations for the next 12-18 months given the continued net losses.
- Design Starts: Track the conversion rate of the 21 Confirmed Design Starts into future royalty-bearing volume production.